View in EDS

Pembrolizumab plus chemotherapy following lack of response to nivolumab-based therapy in MSI-High/dMMR advanced gastric cancer: a case report.

Saved in:
Bibliographic Details
Title: Pembrolizumab plus chemotherapy following lack of response to nivolumab-based therapy in MSI-High/dMMR advanced gastric cancer: a case report.
Authors: Kawabata R; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan.; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan., Hara H; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Takeoka T; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Yasuhara Y; Department of Pathology, Sakai City Medical Center, Sakai, Japan., Yoshihara T; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Kitagawa A; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Takeda T; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Tomihara H; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Naito A; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Murakami M; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Noura S; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Miyamoto A; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan.
Source: International cancer conference journal [Int Cancer Conf J] 2026 Feb 18; Vol. 15 (2), pp. 234-240. Date of Electronic Publication: 2026 Feb 18 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 101734231 Publication Model: eCollection Cited Medium: Internet ISSN: 2192-3183 (Electronic) Linking ISSN: 21923183 NLM ISO Abbreviation: Int Cancer Conf J Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2192-3183
DOI:10.1007/s13691-026-00847-5